Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,293 | 15,173 | 12,795 | 16,734 | 11,649 |
| TOTAL | $88,019 | $17,198 | $15,250 | $19,749 | $13,787 |
| Non-Current Assets | |||||
| PPE Net | 438 | 483 | 522 | 238 | 271 |
| Intangibles | 11,148 | 11,148 | 11,148 | 11,148 | 11,148 |
| Other Non-Current Assets | 179 | 202 | 224 | 245 | 266 |
| TOTAL | $11,765 | $11,833 | $11,894 | $11,631 | $11,685 |
| Total Assets | $99,784 | $29,031 | $27,144 | $31,380 | $25,472 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,578 | 2,920 | 3,438 | 3,739 | 3,235 |
| TOTAL | $4,578 | $2,920 | $3,438 | $3,739 | $3,235 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,690 | 8,351 | 9,239 | 12,012 | 6,945 |
| TOTAL | $6,690 | $8,351 | $9,239 | $12,012 | $6,945 |
| Total Liabilities | $11,268 | $11,271 | $12,677 | $15,751 | $10,180 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76 | 76 | 28 | 27 | 27 |
| Common Shares | 28 | 69 | 62 | 60 | 53 |
| Retained earnings | -61,361 | -56,916 | -54,277 | -50,882 | -40,770 |
| Other shareholders' equity | 61 | -64 | 33 | 23 | -2 |
| TOTAL | $88,516 | $17,760 | $14,467 | $15,629 | $15,292 |
| Total Liabilities And Equity | $99,784 | $29,031 | $27,144 | $31,380 | $25,472 |